2020 annual financial data
Iovance Biotherapeutics 2020 Operating margin
Iovance Biotherapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -261,937,000 USD and net income was -259,581,000 USD.
Operating cash flow was -205,134,000 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -261,937,000 USD
- Net income
- -259,581,000 USD
- Operating cash flow
- -205,134,000 USD